Monoclonal antibody therapy of diffuse cutaneous scleroderma with CAMPATH-1H.
A worker in a polyvinyl chloride factory with rapidly progressive diffuse cutaneous scleroderma was treated with the humanized monoclonal antibody (Mab) CAMPATH-1H. Treatment was followed by rapid and substantial improvement in skin score, which was maintained during followup without additional ther...
Full description
Bibliographic Details
Main Authors: |
Isaacs, J,
Hazleman, B,
Chakravarty, K,
Grant, J,
Hale, G,
Waldmann, H |
Format: | Journal article
|
Language: | English |
Published: |
1996
|